Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 4 Study of YUTIQ® (Fluocinolone Acetonide Intravitreal Implant) 0.18 mg in the Treatment of Chronic Non-Infectious Posterior Segment Uveitis (Intraocular Inflammation Study)

NCT05322070 is registered in ClinicalTrials.gov with Alimera Sciences as lead sponsor.

NCT NCT05322070
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05322070 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 4 Study of YUTIQ® (Fluocinolone Acetonide Intravitreal Implant) 0.18 mg in the Treatment of Chronic Non-Infectious Posterior Segment Uveitis (Intraocular Inflammation Study)
Lead sponsor
Alimera Sciences
Phase
Phase 4
Overall status
Active, not recruiting
Start date
June 6, 2022
Completion date
November 30, 2025
Enrollment
125 (estimated)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

uveitis, posterior